Stay updated with breaking news from Shared Decision Making. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mirna Chehade, MD, MPH, discusses ongoing trials for emerging therapies in eosinophilic esophagitis (EoE), her views on the use of combination therapies, and the importance of shared decision-making for the chronic management of EoE throughout the different phases of a patient’s life.
Clinicians explore disparities and similarities in desmoid tumor treatment approaches between academic and community settings, considering access to clinical trials, shared decision-making, and patient education for better outcomes.
Mirna Chehade, MD, MPH, discusses the challenges faced by patients with eosinophilic esophagitis (EoE), including the absence of predictive factors for personalized treatment, the social implications of dietary restrictions, and the need for invasive procedures, while emphasizing the importance of regularly scheduled follow-up visits to address medical, nutritional, and psychosocial factors for better outcomes.
Mirna Chehade, MD, MPH, discusses the impact of adverse events on influencing treatment decisions for eosinophilic esophagitis (EoE) in pediatric patients, and considerations for the use of biologics.
Mirna Chehade, MD, MPH, emphasizes the value of proton pump inhibitors, swallowed corticosteroids, and dietary restrictions as therapeutic options for pediatric patients with eosinophilic esophagitis (EoE), while underscoring the importance of shared decision-making to maintain adherence and achieve better outcomes.